Dyskinesia Global Clinical Trials Review, H1, 2015

Dyskinesia Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2577CTIDB
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Dyskinesia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Dyskinesia Global Clinical Trials Review, H1, 2015" provides data on the Dyskinesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyskinesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyskinesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Dyskinesia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Dyskinesia 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Dyskinesia Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Dyskinesia 34

Feb 09, 2015: Adamas Pharmaceuticals' Phase 2/3 Clinical Study Published in Movement Disorders 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Ipsen S.A. 35

Clinical Trial Overview of Ipsen S.A. 35

Neurocrine Biosciences, Inc. 37

Clinical Trial Overview of Neurocrine Biosciences, Inc. 37

Allergan, Inc. 38

Clinical Trial Overview of Allergan, Inc. 38

Merz Pharma GmbH & Co. KgaA 39

Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 39

Novartis AG 40

Clinical Trial Overview of Novartis AG 40

Auspex Pharmaceuticals, Inc. 41

Clinical Trial Overview of Auspex Pharmaceuticals, Inc. 41

UCB S.A. 42

Clinical Trial Overview of UCB S.A. 42

Eisai Co., Ltd. 43

Clinical Trial Overview of Eisai Co., Ltd. 43

E. Merck KG 44

Clinical Trial Overview of E. Merck KG 44

Adamas Pharmaceuticals, Inc. 45

Clinical Trial Overview of Adamas Pharmaceuticals, Inc. 45

Clinical Trial Overview of Top Institutes / Government 46

National Institute of Neurological Disorders and Stroke 46

Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 46

University Health Network 47

Clinical Trial Overview of University Health Network 47

University of Florida 48

Clinical Trial Overview of University of Florida 48

Oregon Health & Science University 49

Clinical Trial Overview of Oregon Health & Science University 49

Leiden University Medical Center 50

Clinical Trial Overview of Leiden University Medical Center 50

Rush University Medical Center 51

Clinical Trial Overview of Rush University Medical Center 51

Seoul National University Hospital 52

Clinical Trial Overview of Seoul National University Hospital 52

Taoyuan Mental Hospital 53

Clinical Trial Overview of Taoyuan Mental Hospital 53

University of Iowa 54

Clinical Trial Overview of University of Iowa 54

Vanderbilt University 55

Clinical Trial Overview of Vanderbilt University 55

Five Key Clinical Profiles 56

Appendix 98

Abbreviations 98

Definitions 98

Research Methodology 99

Secondary Research 99

About GlobalData 100

Contact Us 100

Disclaimer 100

Source 100

List of Figures

Dyskinesia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Dyskinesia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Dyskinesia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 99

List of Tables

Dyskinesia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Dyskinesia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Dyskinesia Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Dyskinesia Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Dyskinesia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Dyskinesia Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 35

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2015* 37

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 38

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2015* 39

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 40

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Auspex Pharmaceuticals, Inc., 2015* 41

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2015* 42

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 43

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 44

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamas Pharmaceuticals, Inc., 2015* 45

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 46

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 47

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 48

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 49

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 50

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2015* 51

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 52

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Taoyuan Mental Hospital, 2015* 53

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Iowa, 2015* 54

Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Dyskinesia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Dyskinesia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162350
Site License
USD 5000 INR 324700
Corporate User License
USD 7500 INR 487050

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com